Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Lineage Cell Therapeutics, Inc.
Previous 10% Owner at Insight Molecular Diagnostics. Filing since 5 Jul 2019.
CIK 0000876343
Company
Date
Role
Action
Shares
Amount
Of holding
IMDX
Insight Molecular Diagnostics Inc.
2 Jan 2020
Previous 10% Owner
Sold, plan not stated
2,383,090
$5.14M
28.3%
IMDX
Insight Molecular Diagnostics Inc.
11 Sep 2019
10% owner
Sold, plan not stated
4,000,000
$6.64M
32.2%
IMDX
Insight Molecular Diagnostics Inc.
5 Jul 2019
10% owner
Sold, plan not stated
2,250,000
$4.50M
15.3%
3 decisions on file.
